Motley Fool Money
Motley Fool Money
The Motley Fool
Dunkin', Kendrick on Offense at Super Bowl
30 minutes Posted Feb 10, 2025 at 9:10 pm.
The big game didn’t live up to the big billing, but there was plenty to take in during commercial breaks and halftime.
David Meier and Dylan Lewis discuss:- HIMS taking a big swing at the weight-loss industry, trying to seize a tight window for acquiring customers that want GLP-1 drugs and shift public opinion on them.- Dunkin’ and Starbucks taking very different approaches for morning coffee drinkers.- McDonald’s lackluster Super Bowl ad and earnings results. WSJ article on HIMS: https://www.wsj.com/health/pharma/hims-super-bowl-ad-spotlights-weight-loss-drug-copycats-as-clock-ticks-on-their-business-3a225c5c
0:00
30:02
Download MP3
Show notes
The big game didn’t live up to the big billing, but there was plenty to take in during commercial breaks and halftime. (00:14) David Meier and Dylan Lewis discuss:- HIMS taking a big swing at the weight-loss industry, trying to seize a tight window for acquiring customers that want GLP-1 drugs and shift public opinion on them.- Dunkin’ and Starbucks taking very different approaches for morning coffee drinkers.- McDonald’s lackluster Super Bowl ad and earnings results. WSJ article on HIMS: https://www.wsj.com/health/pharma/hims-super-bowl-ad-spotlights-weight-loss-drug-copycats-as-clock-ticks-on-their-business-3a225c5c (21:35) Robert Brokamp and Alison Southwick continue their conversation on 401ks and how you can get yours in better shape.Companies discussed: HIMS, LLY, NVO, SBUX, SKX, MCDHost: Dylan LewisGuests: David Meier, Robert Brokamp, Alison SouthwickProducer: Ricky MulveyEngineers: Rick Engdahl Learn more about your ad choices. Visit megaphone.fm/adchoices